Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2018

  • ID: 4538985
  • Clinical Trials
  • Region: Global
  • 2411 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • Celgene Corp
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2018

Summary

The clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2018" provides an overview of Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the author's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • Celgene Corp
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Non-Hodgkin Lymphoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Non-Hodgkin Lymphoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Non-Hodgkin Lymphoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Non-Hodgkin Lymphoma
  • Apr 04, 2018: Nordic Nanovector Provides Update on the Humalutin Clinical Development Program
  • Mar 15, 2018: Nordic Nanovector to Present Preclinical Data Highlighting the Anti-tumour Effect of Humalutin in Three Lymphoma Models at AACR 2018
  • Jan 17, 2018: Curis Announces Initiation of Phase 1 Trial of CA-4948, a Small Molecule Inhibitor of IRAK4 Kinase in Patients with Lymphoma
  • Jan 16, 2018: Gamida Cell Announces Initiation of a Phase I Study of NAM-NK Cells Immunotherapy Program for Non-Hodgkin Lymphoma and Multiple Myeloma
  • Clinical Trial Profile Snapshots
  • Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About
  • Contact
  • Disclaimer
  • Source
List of Tables
  • Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region, 2018*
  • Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018*
  • Proportion of Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2018*
  • Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Non-Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2018*
  • Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2018*
  • Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2018*
  • Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
List of Figures
  • Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2018*
  • Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018*
  • Proportion of Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2018*
  • Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Non-Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2018*
  • Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2018*
  • Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2018*
  • Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
  • Methodology 2
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • F. Hoffmann-La Roche Ltd
  • Celgene Corp
  • Johnson & Johnson
  • Takeda Pharmaceutical Co Ltd
  • Novartis AG
  • GlaxoSmithKline Plc
  • AbbVie Inc
  • Amgen Inc
  • Pfizer Inc
  • Sanofi
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll